首页 » 文章 » 文章详细信息
BioMed Research International Volume 2019 ,2019-07-24
Safety and Effectiveness of Mist Antiaris, a Herbal Preparation for Treatment of Peripheral Neuropathy
Research Article
S. Antwi 1 J. Asiedu-Larbi 1 O. N. K. Martey 1 O. Quasie 1 M. Boakye-Yiadom 2 F. Ayertey 1 R. Yeboah 2 C. A. Sapaty 2 D. Offei-Abrokwa 2 D. Oduro-Mensah 3 E. K. Kumatia 4 A. Ocloo 1 , 5
Show affiliations
DOI:10.1155/2019/2607872
Received 2019-01-08, accepted for publication 2019-07-07, Published 2019-07-07
PDF
摘要

Mist Antiaris is a herbal decoction for treatment of nervous disorders. Safety and efficacy were evaluated in Sprague-Dawley rats and human patients, respectively. Acute toxicity was assessed by administration of a single 5000 mg/kg oral dose of decoction to a group of six rats. For subchronic toxicity, four groups of six rats each received water (control) or 10, 100, or 200 mg/kg oral doses of decoction daily for eight weeks. Body weight, serum, urine, and hematological profile of the animals in each group were monitored over the period. Effects of treatment on pentobarbital-induced sleeping time and histology of liver, lung, heart, and kidney tissue were assessed at the end of the study. There was no evidence of acute toxicity within 48 hours of the oral dose. Over the 8-week period, body weight increases in Mist Antiaris treatment groups were reduced relative to the control group. There were no significant differences in urine profile, serum biochemistry, hematological parameters, and pentobarbital-induced sleeping time. Tissue histology revealed no differences relative to controls. Assessment of efficacy was by retrospective review of data on patients who presented with peripheral neuropathy. Treatment resulted in 53.7 % of patients reporting complete resolution and 15.7 % showing reduction in neuropathic symptoms. The data demonstrate that there is no toxicity due to subchronic administration of Mist Antiaris in Sprague-Dawley rats. The reduction or resolution of neuropathic symptoms indicated by patents’ file data provides evidence to suggest that Mist Antiaris has antineuropathic effects.

授权许可

Copyright © 2019 S. Antwi et al. 2019
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

通讯作者

1. S. Antwi.Pharmacology and Toxicology Department, Centre for Plant Medicine Research, P. O. Box 73, Mampong, Akuapem, Ghana.stephen.antwi@cpmr.gov.gh
2. A. Ocloo.Pharmacology and Toxicology Department, Centre for Plant Medicine Research, P. O. Box 73, Mampong, Akuapem, Ghana;Department of Biochemistry, Cell and Molecular Biology, University of Ghana, P. O. Box LG 54, Legon, Ghana, ug.edu.gh.aocloo@ug.edu.gh

推荐引用方式

S. Antwi,J. Asiedu-Larbi,O. N. K. Martey,O. Quasie,M. Boakye-Yiadom,F. Ayertey,R. Yeboah,C. A. Sapaty,D. Offei-Abrokwa,D. Oduro-Mensah,E. K. Kumatia,A. Ocloo. Safety and Effectiveness of Mist Antiaris, a Herbal Preparation for Treatment of Peripheral Neuropathy. BioMed Research International ,Vol.2019(2019)

您觉得这篇文章对您有帮助吗?
分享和收藏
0

是否收藏?

参考文献
[1] J. Edward, K. L. Bastyr, B. Price Vera. (2005). Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clinical Therapeutics.27(8):1278-1294. DOI: 10.1016/j.jdiacomp.2006.08.002.
[2] S. D. Candrilli, K. L. Davis, H. J. Kan, M. A. Lucero. et al.(2007). Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. Journal of Diabetes and its Complications.21(5):306-314. DOI: 10.1016/j.jdiacomp.2006.08.002.
[3] M. D. Olufunke, F. U. Zaki. (2013). Chemical constituents of the leaf, stem-bark and root essential oils of antiaris africana. Journal of Applied Pharmaceutical Science.3(6):168-171. DOI: 10.1016/j.jdiacomp.2006.08.002.
[4] A. Banso, A. Mann. (2008). Evaluation of antibacterial properties of flavonoid fraction from Antiaris africana Engl. Journal of Applied Biosciences.12:665-670. DOI: 10.1016/j.jdiacomp.2006.08.002.
[5] A. Gaw, A. R. Cowan, S. J. OReilly, M. J. Stewart. et al.(1998). Clinical Biochemistry : An Illustrated Colour Text. DOI: 10.1016/j.jdiacomp.2006.08.002.
[6] S. J. Chen, J. H. Liu, H. C. Shih, P. Chou. et al.(2008). Prevalence and associated factors of lens opacities among Chinese type 2 diabetics in Kinmen, Taiwan. Acta Diabetologica.45(1):7-13. DOI: 10.1016/j.jdiacomp.2006.08.002.
[7] V. Kuete, B. Vouffo, A. T. Mbaveng, E. Y. Vouffo. et al.(2009). Evaluation of methanol extract and compounds for antioxidant and antitumor activities. Pharmaceutical Biology/International Journal of Pharmacognosy.47(11):1042-1049. DOI: 10.1016/j.jdiacomp.2006.08.002.
[8] P. K. Mukherjee. (2002). Quality control of herbal drugs. An approach to elucidation of Botanicals. G-59, Masjid Moth GK-2:522-524. DOI: 10.1016/j.jdiacomp.2006.08.002.
[9] A. K. Nyarko, N.-A. Ankrah, M. Ofosuhene, A. A. Sittie. et al.(1999). Acute and Sub-chronic evaluation of : absence of both toxicity and modulation of selected cytochrome P450 in doy mice. Phytotherapy Research.13(8):686-688. DOI: 10.1016/j.jdiacomp.2006.08.002.
[10] A. Chawla, G. Bhasin, R. Chawla. (2013). Validation of Neuropathy Symptoms Score (nss) and neuropathy disability score (nds) in the clinical diagnosis of peripheral neuropathy in middle aged people with diabetes. The Internet Journal of Family Practice.12(1). DOI: 10.1016/j.jdiacomp.2006.08.002.
[11] G. G. Gibson, P. Skett. (1994). Introduction to Drug Metabolism. DOI: 10.1016/j.jdiacomp.2006.08.002.
[12] I. Amissah, M. Amoako-Boateng. (2014). Prevalence of diabetes mellitus complications among people with type 2 diabetes mellitus attending a teaching hospital in ghana: a clinical audit. International Journal of Science and Research.11(3):2319-7064. DOI: 10.1016/j.jdiacomp.2006.08.002.
[13] A. Asad, M. A. Hameed, U. A. Khan, N. Ahmed. et al.(2010). Reliability of the neurological scores for assessment of sensorimotor neuropathy in type 2 diabetics. Journal of the Pakistan Medical Association.60(3):166-170. DOI: 10.1016/j.jdiacomp.2006.08.002.
[14] O. B. Ilesanmi, T. M. Olaleye, A. C. Akinmoladun, T. T. Alawode. et al.(2016). HPLC quantification of phenolic content and assessment of methanolic extract of Antiaris africana for toxicological study. African Journal of Biotechnology.15(9):320-330. DOI: 10.1016/j.jdiacomp.2006.08.002.
[15] J. I. Okogun, A. I. Spiff, D. E. U. Ekong. (1976). Triterpenoids and betaines from the latex and bark of Engl. Phytochemistry.15(5):826-827. DOI: 10.1016/j.jdiacomp.2006.08.002.
[16] V. Bertin, H. Hussain, S. F. Kouam, E. Dongo. et al.(2008). Antialactone: a new -lactone from , and its absolute configuration determined from TDDFT CD calculations. Natural Product Communications (NPC).3(2):215-218. DOI: 10.1016/j.jdiacomp.2006.08.002.
文献评价指标
浏览 5次
下载全文 0次
评分次数 0次
用户评分 0.0分
分享 0次